Page 0066

EPIDEMIOLOGY

commitment to training analysts in cancer survival measured gets done.” Global inequalities in cancer survival

techniques. The training programme is designed to help are wide, and potentially avoidable. Unless they are

improve the capacity of cancer registries to undertake measured, and reported regularly, nothing will be done to

survival analyses independently. The Cancer Survival Group ameliorate them.

at the London School of Hygiene has run annual courses since Global surveillance of cancer survival will shine a new light

2006. Over 300 students from 40 countries have attended on the effectiveness of national health systems in managing

these courses, and a further 350 or so have attended our the world’s growing cancer burden. Surveillance will highlight

courses and advanced workshops in seven other countries in international differences, national trends and racial/ethnic

the last few years. The capacity-building component of the inequalities in cancer survival. The information will stimulate

CONCORD programme is growing, and we are seeking cancer patients, the wider public and politicians to seek

training fellowships to support cancer registry scientists from improvement. l

low- and middle-income countries.

Professor Michel P Coleman qualified in medicine in Oxford last

Global spotlight on noncommunicable disease century and practised in internal medicine and general practice

The United National General Assembly High-Level Meeting before deserting to epidemiology. He worked in the Cancer

in New York in September 2011 set new strategic objectives Epidemiology Unit in Oxford (1984–87), at WHO’s

for worldwide control of noncommunicable diseases54. The International Agency for Research on Cancer in Lyon

UN resolution emphasized the need for wider research into (1987–1991), and as Medical Director of the Thames Cancer

global prevention and control of all noncommunicable Registry in London (1991–95). He has been Professor of

diseases, including cancer, because of their rapidly growing Epidemiology and Vital Statistics at the London School of

impact on public health in developing countries in particular. Hygiene & Tropical Medicine since 1995.

At a preparatory conference in Russia in April 2011, Dr His research has focused on time trends and socioeconomic

Margaret Chan, WHO Director-General, said: “Without inequalities in cancer incidence, mortality and survival, and their

global goals or targets, this is not going to fly – what gets application to improve public health policy for cancer control.

References

1.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA health insurance coverage. Arch Intern Med 2003; 163: 2135-44

Cancer J Clin 2011; 61: 69-90 http://dx.doi.org/10.3322/caac.20107 10.

Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, Law

2.

International Atomic Energy Agency. Inequity in cancer care: a global perspective. IAEA SCK, Ahn YO, Xiang YB, Yeole BB, Shin HR, Shanta V, Woo ZH, Martin N, Sumitsawan

Human Health Reports No. 3 . Vienna, IAEA, 2011. Y, Sriplung H, Barboza AO, Eser S, Nene BM, Suwanrungruang K, Jayalekshmi P,

3.

Coleman MP, Quaresma M, Berrino F, Lutz J-M, De Angelis R, Capocaccia R, Baili P, Dikshit R, Wabinga H, Esteban DB, Laudico A, Bhurgri Y, Bah E, Al-Hamdan N. Cancer

Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol

Koifman S, Azevedo e Silva G, Francisci S, Santaquilani M, Verdecchia A, Storm HH, 2010; 11: 165-73 PM:20005175

11.

Young JL, CONCORD Working Group. Cancer survival in five continents: a Anderson BO, Cazap E, El Saghir NS, Yip CH, Khaled HM, Otero IV, Adebamowo CA,

worldwide population-based study (CONCORD). Lancet Oncol 2008; 9: 730-56 Badwe RA, Harford JB. Optimisation of breast cancer management in low-resource

4.

Mostert S, Arora RS, Arreola M, Bagai P, Friedrich P, Gupta S, Kaur G, Koodiyedath B, and middle-resource countries: executive summary of the Breast Health Global

Kulkarni K, Lam CG, Luna-Fineman S, Pizer B, Rivas S, Rossell N, Sitaresmi MN, Initiative consensus, 2010. Lancet Oncol 2011; 12: 387-98

Tsimicalis A, Weaver M, Ribeiro RC. Abandonment of treatment for childhood cancer: http://linkinghub.elsevier.com/retrieve/pii/S1470204511700316

12.

position statement of a SIOP PODC Working Group. Lancet Oncol 2011 Berrino F, Capocaccia R, Coleman MP, Estève J, Gatta G, Hakulinen T, Micheli A, Sant

PM:21719348 M, Verdecchia A, eds. Survival of cancer patients diagnosed in Europe: the

5.

Micheli A, Coebergh JWW, Mugno E, Massimiliani E, Sant M, Oberaigner W, Holub J, EUROCARE-3 study. Ann Oncol 2003; 14 (Suppl. 5): pp1-155

13.

Storm HH, Forman D, Quinn MJ, Aareleid T, Sankila R, Hakulinen T, Faivre J, Ziegler Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JWW, Santaquilani M,

H, Tryggvadóttir L, Zanetti R, Dalmas M, Visser O, Langmark F, Bielska-Lasota M, EUROCARE Working Group. Survival for eight major cancers and all cancers

Wronkowski Z, Pinheiro PS, Brewster DH, Pleško I, Pompe-Kirn V, Martinez-Garcia combined for European adults diagnosed in 1995-99: results of the EUROCARE-4

C, Barlow L, Moller T, Lutz J-M, Andre M, Steward JA. European health systems and study. Lancet Oncol 2007; 8: 773-83

cancer care. Ann Oncol 2003; 14 (Suppl. 5): 41-61 14.

Capocaccia R, Gavin A, Hakulinen T, Lutz J-M, Sant M, eds. Survival of cancer patients

6.

Vercelli M, Lillini R, Capocaccia R, Micheli A, Coebergh JWW, Quinn M, Martinez- diagnosed in Europe, 1995-2002: the EUROCARE-4 study. Eur J Cancer 2009; 45

Garcia C, Quaglia A. Cancer survival in the elderly: effects of socio-economic factors (Suppl. 6): pp901-1094

and health care system features (ELDCARE project). Eur J Cancer 2006; 42: 234-42 15.

Commission of the European Communities. Communication from the Commission to

PM:16359860 the European Parliament, the Council, the European Economic and Social Committee

7.

Kogevinas M, Porta M. Socioeconomic differences in cancer survival: a review of the and the Committee of the Regions on Action against Cancer: European Partnership.

evidence. In: Kogevinas M, Pearce N, Susser M, Boffetta P, eds. Social inequalities and Commission of the European Communities 24 Jun 2009.

cancer. (IARC Scientific Publications No. 138). Lyon: International Agency for http://ec.europa.eu/health/ph_information/dissemination/diseases/docs/com_2009_2

Research on Cancer; 1997, pp177-206. 91.en.pdf, last accessed 24 June 2009.

8. 16.

Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer Coleman MP, Alexe DM, Albreht T, McKee CM, eds. Responding to the challenge of

survival: a review. Ann Oncol 2006; 17: 5-19 doi:10.1093/annonc/mdj007 cancer in Europe. Ljubljana: Institute of Public Health of the Republic of Slovenia;

9.

McDavid K, Tucker T, Sloggett A, Coleman MP. Cancer survival in Kentucky and 2008, pp1-327

64 CANCER CONTROL 2013

Index

  1. CANCER CONTROL 2013
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038
  39. Page 0039
  40. Page 0040
  41. Page 0041
  42. Page 0042
  43. Page 0043
  44. Page 0044
  45. Page 0045
  46. Page 0046
  47. Page 0047
  48. Page 0048
  49. Page 0049
  50. Page 0050
  51. Page 0051
  52. Page 0052
  53. Page 0053
  54. Page 0054
  55. Page 0055
  56. Page 0056
  57. Page 0057
  58. Page 0058
  59. Page 0059
  60. Page 0060
  61. Page 0061
  62. Page 0062
  63. Page 0063
  64. Page 0064
  65. Page 0065
  66. Page 0066
  67. Page 0067
  68. Page 0068
  69. Page 0069
  70. Page 0070
  71. Page 0071
  72. Page 0072
  73. Page 0073
  74. Page 0074
  75. Page 0075
  76. Page 0076
  77. Page 0077
  78. Page 0078
  79. Page 0079
  80. Page 0080
  81. Page 0081
  82. Page 0082
  83. Page 0083
  84. Page 0084
  85. Page 0085
  86. Page 0086
  87. Page 0087
  88. Page 0088
  89. Page 0089
  90. Page 0090
  91. Page 0091
  92. Page 0092
  93. Page 0093
  94. Page 0094
  95. Page 0095
  96. Page 0096
  97. Page 0097
  98. Page 0098
  99. Page 0099
  100. Page 0100
  101. Page 0101
  102. Page 0102
  103. Page 0103
  104. Page 0104
  105. Page 0105
  106. Page 0106
  107. Page 0107
  108. Page 0108
  109. Page 0109
  110. Page 0110
  111. Page 0111
  112. Page 0112
  113. Page 0113
  114. Page 0114
  115. Page 0115
  116. Page 0116
  117. Page 0117
  118. Page 0118
  119. Page 0119
  120. Page 0120
  121. Page 0121
  122. Page 0122
  123. Page 0123
  124. Page 0124
  125. Page 0125
  126. Page 0126
  127. Page 0127
  128. Page 0128
  129. Page 0129
  130. Page 0130
  131. Page 0131
  132. Page 0132
  133. Page 0133
  134. Page 0134
  135. Page 0135
  136. Page 0136
  137. Page 0137
  138. Page 0138
  139. Page 0139
  140. Page 0140
  141. Page 0141
  142. Page 0142
  143. Page 0143
  144. Page 0144
  145. Page 0145
  146. Page 0146
  147. Page 0147
  148. Page 0148
  149. Page 0149
  150. Page 0150
  151. Page 0151
  152. Page 0152
  153. Page 0153
  154. Page 0154
  155. Page 0155
  156. Page 0156
  157. Page 0157
  158. Page 0158
  159. Page 0159
  160. Page 0160
  161. Page 0161
  162. Page 0162
  163. Page 0163
  164. Page 0164
  165. Page 0165
  166. Page 0166
  167. Page 0167
  168. Page 0168
  169. Page 0169
  170. Page 0170
  171. Page 0171
  172. Page 0172
  173. Page 0173
  174. Page 0174
  175. Page 0175
  176. Page 0176
  177. Page 0177
  178. Page 0178
  179. Page 0179
  180. Page 0180

powered by PageTiger